| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2798218 | Diabetes Research and Clinical Practice | 2008 | 6 Pages |
AimTo explore the feasibility of withdrawal of diabetes medication in elderly patients with HbA1c ≤ 6.0%.MethodsHbA1c was measured in 98 patients with known diabetes in 17 nursing homes in Sweden. Thirty-two subjects with HbA1c ≤6.0% participated in the drug withdrawal study. After measuring plasma glucose on 3 consecutive days, diabetes drugs were reduced, i.e. complete withdrawal of oral anti-diabetic drugs (OADs), complete insulin withdrawal when doses were ≤20 units/day and reduced by half in patients on more than 20 units/day.ResultsWe identified 31 episodes of plasma glucose ≤4.4 mmol/l, most of them nocturnal (n = 17). Mean HbA1c was 5.2 ± 0.4% compared to 7.1 ± 1.6% in the non-intervention group. Three months after the diabetes drug discontinuation, 24 patients (75%) remained in the intervention group and mean HbA1c was then 5.8. ± 0.9%. Six months after baseline investigation mean HbA1c in the intervention group was 5.8 ± 1.1% compared with 6.6 ± 1.4% in the non-intervention group.ConclusionsHypoglycaemic events are common among elderly patients with type 2 diabetes. The withdrawal of diabetes medication in elderly with tight glycaemic control is safe and may decrease the risk for hypoglycaemia.
